drugset / Trial / NCT00047034

E7389 in Treating Patients With Advanced Solid Tumors

NCT00047034

Phase 1 Completed 31 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of E7389 in treating patients who have advanced solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die

Timeline

Start
2002-08
Primary completion
2007-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Eribulin Small molecule Intravenous